ADDUS HOMECARE CORPORATION

NASDAQ: ADUS (Addus HomeCare Corporation)

Last update: 3 days ago, 1:42PM

98.08

-0.06 (-0.07%)

Previous Close 98.14
Open 98.42
Volume 77,806
Avg. Volume (3M) 248,893
Market Cap 1,830,547,840
Price / Earnings (TTM) 18.79
Price / Earnings (Forward) 14.37
Price / Sales 1.27
Price / Book 1.69
52 Weeks Range
90.89 (-7%) — 124.44 (26%)
Earnings Date 4 May 2026
Profit Margin 6.52%
Operating Margin (TTM) 9.04%
Diluted EPS (TTM) 4.42
Quarterly Revenue Growth (YOY) 20.30%
Quarterly Earnings Growth (YOY) 34.10%
Total Debt/Equity (MRQ) 25.20%
Current Ratio (MRQ) 1.74
Operating Cash Flow (TTM) 96.70 M
Levered Free Cash Flow (TTM) 52.88 M
Return on Assets (TTM) 6.52%
Return on Equity (TTM) 9.18%

Market Trend

Short Term Medium Term
Industry Medical Care Facilities (US) Bullish Bullish
Medical Care Facilities (Global) Bullish Bullish
Stock Addus HomeCare Corporation Bearish Bearish

AIStockmoo Score

2.3
Analyst Consensus 3.0
Insider Activity NA
Price Volatility 1.5
Technical Moving Averages 2.5
Technical Oscillators 2.0
Average 2.25

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
ADUS 2 B - 18.79 1.69
OPCH 3 B - 15.88 3.18
AMED 3 B - 35.42 2.69
ASTH 2 B - 76.12 2.49
JYNT 130 M - - 8.60
ENSG 11 B 0.14% 32.37 4.93

Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, mainly to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are medical in nature to those individuals who may require assistance during an illness or after surgery.

Sector Healthcare
Industry Medical Care Facilities
Investment Style Small Core
% Held by Insiders 2.58%
% Held by Institutions 102.78%
52 Weeks Range
90.89 (-7%) — 124.44 (26%)
Price Target Range
112.00 (14%) — 135.00 (37%)
High 135.00 (Stephens & Co., 37.65%) Buy
Median 123.50 (25.92%)
Low 112.00 (Barclays, 14.20%) Sell
Average 123.50 (25.92%)
Total 1 Buy, 1 Sell
Avg. Price @ Call 106.40
Firm Date Target Price Call Price @ Call
Stephens & Co. 25 Feb 2026 135.00 (37.65%) Buy 107.60
Barclays 24 Feb 2026 112.00 (14.20%) Sell 105.20

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria